Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?

To: Del Holmes who wrote (268)	4/4/1998 1:31:00 PM
From: rodin999	Respond to of 783

you're right the level of content on this post is much higher than the standard posts, however it seems we have quality but very little quantity at all......i would love to see a commitment from us to post one comment or question a day...what do you guys think... re:clinichem i read a recent research report that the clinichem spinoff presents a buying opportunity for BCHE....since the spin off will value between 4-6 CAD each.... the research report went on to say that once trading in Clinichem starts there will be considerable selling pressure as most BCHE holders will take the immediate gain by selling the shares. This will create a short window of buying opportunity during this selling pressure... as far as investing in clinichem, i dunno. I intend to hold my shares (i'll probably get only five shares) but i'll just leave them and maybe buy more if it drops down to 3-4....i would think that buying clinichem is like buying a small unproven biotech that maybe has a drug in the pipeline.... with the lisbon conference, short position and annual meeting + q1 results i dont think the stock will have time to consolidate....i'm predicting $30 by the end of April...lets see how close I am.....you guys have any predictions?